Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Tackle Zero Based Budgeting And Child Expenses with methods that allocate funds for loved ones without compromising long-term goals.
28,655 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Investors eye SpaceX's potential IPO as the space economy broadens; public peers already provide exposure across laun...
June card spending rose 6.3% year over year, with wage gains across all income groups. The latest bofa consumer chief...
Adecoagro (AGRO) investors eye the 2025 earnings path as commodity markets, currency volatility, and crop yields shap...
Two automotive giants draw the attention of investors with shifting revenue engines. This deep dive breaks down Ford ...
Contrarian investors are eyeing simply good foods stock as a potential turnaround play. This article breaks down the ...
The race to a cleaner power grid is accelerating. Projected annual global renewable energy investment could reach $2....
When a blue-chip name like Microsoft moves, it can shake nerves and portfolios. This guide explains why microsoft sto...
SpaceX is expanding beyond rockets with a bold $60B Cursor deal. This strategic shift could redefine how investors va...
A sharp 20% drop has many investors asking if PayPal stock is a bargain or a value trap. This guide breaks down the b...
Nuscale Power stock has drawn attention for a potential 195% upside from some analysts. This article breaks down what...
Blue (OBDC) 2025 earnings could signal how well the firm leverages private credit trends and cost discipline. This gu...